HANNAH KRAUS: Open Payments
NPI 1639898836 · PETERSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$765 in 46 payments from 16 companies in 2025. Trend: 2023 $61 · 2024 $326 · 2025 $765
Food & beverage: $747Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $139 |
| Lilly USA, LLC | 4 | $83 |
| Amgen Inc. | 5 | $82 |
| AstraZeneca Pharmaceuticals LP | 5 | $78 |
| Novo Nordisk Inc | 3 | $62 |
| Antares Pharma, Inc. | 3 | $56 |
| Lundbeck LLC | 2 | $43 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
Products named: QULIPTA, UBRELVY, XYOSTED, AIRSUPRA, Ozempic, REXULTI, Auvelity, EVENITY.
Industry payments across VA — which companies pay providers there.
